#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Subdural haematoma Lip and/or oral cavity cancer Squamous cell carcinoma of head and neck Porphyria non-acute Follicle centre lymphoma follicular grade I, II – III Alexander disease Oesophageal achalasia Gastrointestinal stromal tumour Hyperadrenocorticism Hypomagnesaemia Juvenile chronic myelomonocytic leukaemia Short-bowel syndrome Asthma Liposarcoma recurrent Endometrial adenocarcinoma More trials…

    Learn about Rare Diseases

    Undifferentiated sarcoma Prolymphocytic leukaemia – Basic Information Atypical teratoid/rhabdoid tumour of CNS – Diagnostics Pemphigoid Choroid melanoma Idiopathic pulmonary fibrosis – Diagnostics Mast cell activation syndrome Nodal marginal zone B-cell lymphoma – Basic Information Stevens-Johnson syndrome – Basic Information Encephalitis autoimmune – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rivaroxaban Dazukibart Abelacimab Doxribtimine Cariprazine Hydrochloride Atorvastatin AMMONIUM (15N) CHLORIDE Catequentinib Dihydrochloride Lenacapavir Soticlestat Zalunfiban Abiraterone Acetate Calcium Folinate ICOTROKINRA Sodium Picosulfate Tub-040 Cefazolin ORX750 Cefotaxime Pp1815 More therapies…

    Learn about Your Condition

    Toxicity to various agents Gaucher's disease type I Patent ductus arteriosus Endometrial stromal sarcoma Cardiovascular disorder Myotonic dystrophy Respiratory failure Anogenital warts Hypersomnia Coronary artery occlusion Gouty arthritis HER2 positive breast cancer White matter lesion Acarodermatitis Atrial flutter More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study to Compare Fianlimab and Cemiplimab Combination with Pembrolizumab in Patients with High-Risk Melanoma After Surgery

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Fianlimab
    • Cemiplimab
    • Pembrolizumab
    Belgium Czechia France Germany Greece Ireland +4

  • Study on Valaciclovir for Treating Advanced Gum Disease in Adults

    Recruiting

    3 1 1
    Investigated Diseases:
    • Periodontitis
    Investigated Drugs:
    • Valaciclovir
    • Cellulose, Microcrystalline
    France

  • Study Comparing Conventional Radiotherapy and PSMA-PET/CT Targeted Treatment with 18F-PSMA-1007 and Gozetotide for Prostate Cancer Recurrence After Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer recurrent
    Investigated Drugs:
    • Gozetotide
    Sweden

  • Study on the Effects of Rifampicin, Amoxicillin, and Moxifloxacin in Treating Prosthetic Joint Infections Caused by Cutibacterium acnes for Affected Patients

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Medical device site joint infection
    Investigated Drugs:
    • Moxifloxacin
    • Amoxicillin
    • Clindamycin
    France

  • Study on Metformin for Prolonging Pregnancy in Women with Preterm Preeclampsia

    Recruiting

    3 1 1
    Investigated Diseases:
    • Pre-eclampsia
    Investigated Drugs:
    • Metformin Hydrochloride
    Finland Norway Sweden

  • Study on Continuing Somatostatin Analogues with Sunitinib, Octreotide, and Lutetium (177Lu) Oxodotreotide for Patients with Neuroendocrine Tumors

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Neuroendocrine tumour
    • Gastroenteropancreatic neuroendocrine tumour disease
    • Pancreatic neuroendocrine tumour
    Investigated Drugs:
    • Lutetium (177Lu) Oxodotreotide
    • Lanreotide
    • Everolimus
    Belgium The Netherlands
Previous Page
1 … 587 588 589 590 591 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!